CARMIEL, Israel (AP) _ Protalix BioTherapeutics Inc. (PLX) on Monday reported a loss of $7.3 million in its first quarter.
On a per-share basis, the Carmiel, Israel-based company said it had a loss of 5 cents.
The drug developer posted revenue of $10.4 million in the period.
The company's shares closed at 44 cents. A year ago, they were trading at 42 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX